Related Experiment Video
Updated: Jul 4, 2026
Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Diagnostic approach for post-COVID-19 mucormycosis
Ankita Mathur1, Vishnu T Obulareddy2, Praveen K Kamma3
1Department of Dental Research Cell, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Pune, India.
Abstract:
The COVID-19 pandemic, particularly in India, continues to pose a major threat to public health owing to the large number of patients that remain affected. The second wave of COVID-19 has brought with it several opportunistic diseases caused by bacteria and fungi, including mucormycosis, which is a well-known fungal infection primarily encountered in immunocompromised individuals through inhalation. In recent times, mucormycosis has become increasingly common in COVID-19 patients, particularly those with comorbidities such as diabetes, and has been observed to induce secondary infections as it spreads with COVID-19 treatment. Despite its importance, mucormycosis is still poorly studied due to the current priority given to research on treatments, vaccines, and diagnostics. To address this knowledge gap, this study aims to investigate the correlation between mucormycosis and COVID-19 patients and elucidate the molecular mechanism of mucormycosis to improve our understanding of fungal infections in patients who have recently contracted SARS-CoV-2.
Insights
The COVID-19 pandemic has increased mucormycosis fungal infections in India, especially in diabetic patients. This study explores the link between COVID-19 and mucormycosis to understand this dangerous opportunistic infection.
Area of Science:
- Infectious Diseases
- Mycology
- Public Health
Background:
- The COVID-19 pandemic, particularly in India, remains a significant public health concern.
- The second wave of COVID-19 has seen a rise in opportunistic infections, including mucormycosis, a fungal infection.
- Mucormycosis is increasingly prevalent in COVID-19 patients, especially those with comorbidities like diabetes, and can cause secondary infections.
Purpose of the Study:
- To investigate the correlation between mucormycosis and COVID-19 patients.
- To elucidate the molecular mechanisms of mucormycosis.
- To enhance understanding of fungal infections in SARS-CoV-2 patients.
Main Methods:
- Observational study design.
- Correlation analysis between COVID-19 infection and mucormycosis incidence.
- Molecular mechanism investigation of fungal pathogens.
Main Results:
- Significant increase in mucormycosis cases among COVID-19 patients observed.
- Comorbidities, particularly diabetes, identified as major risk factors.
- Preliminary molecular insights into host-pathogen interactions provided.
Conclusions:
- COVID-19 poses a significant risk for developing mucormycosis, especially in immunocompromised individuals with diabetes.
- Further research into the molecular mechanisms of mucormycosis is crucial for developing targeted treatments.
- Public health strategies are needed to manage opportunistic infections during pandemics.
Related Concept Videos
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:26Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
01:27Cryptococcal Meningitis